A citation-based method for searching scientific literature

Paul Cumming, Per Borghammer. Curr Top Behav Neurosci 2012
Times Cited: 10







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
20

Intertemporal choice in Parkinson's disease.
Maria Milenkova, Bahram Mohammadi, Katja Kollewe, Christoph Schrader, Anja Fellbrich, Matthias Wittfoth, Reinhard Dengler, Thomas F Münte. Mov Disord 2011
42
20

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
B Scatton, F Javoy-Agid, L Rouquier, B Dubois, Y Agid. Brain Res 1983
579
20


Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease.
Angelo Antonini, Chiara Siri, Gabriella Santangelo, Roberto Cilia, Michele Poletti, Margherita Canesi, Alessandra Caporali, Francesca Mancini, Gianni Pezzoli, Roberto Ceravolo,[...]. Mov Disord 2011
112
20

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
K A Frey, R A Koeppe, M R Kilbourn, T M Vander Borght, R L Albin, S Gilman, D E Kuhl. Ann Neurol 1996
239
10

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
10

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.
Nicolaas I Bohnen, Martijn L T M Müller, Vikas Kotagal, Robert A Koeppe, Michael A Kilbourn, Roger L Albin, Kirk A Frey. Brain 2010
188
10

Impaired attention predicts falling in Parkinson's disease.
L M Allcock, E N Rowan, I N Steen, K Wesnes, R A Kenny, D J Burn. Parkinsonism Relat Disord 2009
124
10

Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease.
Carine Karachi, David Grabli, Frédéric A Bernard, Dominique Tandé, Nicolas Wattiez, Hayat Belaid, Eric Bardinet, Annick Prigent, Hans-Peter Nothacker, Stéphane Hunot,[...]. J Clin Invest 2010
264
10


Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease.
Kathryn A Chung, Brenna M Lobb, John G Nutt, Fay B Horak. Neurology 2010
161
10

In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.
D E Kuhl, S Minoshima, J A Fessler, K A Frey, N L Foster, E P Ficaro, D M Wieland, R A Koeppe. Ann Neurol 1996
274
10

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.
N I Bohnen, D I Kaufer, R Hendrickson, L S Ivanco, B J Lopresti, G M Constantine, Ch A Mathis, J G Davis, R Y Moore, S T Dekosky. J Neurol 2006
202
10




Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
D Aarsland, K Brønnick, J P Larsen, O B Tysnes, G Alves. Neurology 2009
412
10

The interplay of cholinergic function, attention, and falls in Parkinson's disease.
Alison Yarnall, Lynn Rochester, David J Burn. Mov Disord 2011
136
10

Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.
S Heckers, C Geula, M M Mesulam. Neurobiol Aging 1992
26
10

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Christopher G Goetz, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Glenn T Stebbins, Matthew B Stern, Barbara C Tilley, Richard Dodel, Bruno Dubois,[...]. Mov Disord 2007
634
10

Changes in motor subtype and risk for incident dementia in Parkinson's disease.
Guido Alves, Jan Petter Larsen, Murat Emre, Tore Wentzel-Larsen, Dag Aarsland. Mov Disord 2006
283
10

A simple synthesis of [11C]dihydrotetrabenazine (DTBZ).
D M Jewett, M R Kilbourn, L C Lee. Nucl Med Biol 1997
62
10

Optimization of Butterworth filter for brain SPECT imaging.
S Minoshima, H Maruno, N Yui, T Togawa, F Kinoshita, M Kubota, K L Berger, Y Uchida, K Uno, N Arimizu. Ann Nucl Med 1993
11
10


Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.
Caroline H Williams-Gray, Adam Hampshire, Roger A Barker, Adrian M Owen. Brain 2008
117
10


Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity.
S E Snyder, L Tluczek, D M Jewett, T B Nguyen, D E Kuhl, M R Kilbourn. Nucl Med Biol 1998
43
10

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain.
N R Selden, D R Gitelman, N Salamon-Murayama, T B Parrish, M M Mesulam. Brain 1998
380
10

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, J Kulisevsky, D Burn, P Barone, J Pagonabarraga, L Allcock,[...]. Neurology 2010
431
10

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.
Nicolaas I Bohnen, Roger L Albin, Robert A Koeppe, Kristine A Wernette, Michael R Kilbourn, Satoshi Minoshima, Kirk A Frey. J Cereb Blood Flow Metab 2006
171
10

History of falls in Parkinson disease is associated with reduced cholinergic activity.
N I Bohnen, M L T M Müller, R A Koeppe, S A Studenski, M A Kilbourn, K A Frey, R L Albin. Neurology 2009
238
10

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.
R Hilker, A V Thomas, J C Klein, S Weisenbach, E Kalbe, L Burghaus, A H Jacobs, K Herholz, W D Heiss. Neurology 2005
231
10


Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
H Shimada, S Hirano, H Shinotoh, A Aotsuka, K Sato, N Tanaka, T Ota, M Asahina, K Fukushi, S Kuwabara,[...]. Neurology 2009
216
10

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study.
Nicolaas I Bohnen, Daniel I Kaufer, Larry S Ivanco, Brian Lopresti, Robert A Koeppe, James G Davis, Chester A Mathis, Robert Y Moore, Steven T DeKosky. Arch Neurol 2003
371
10


Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
S Gilman, R A Koeppe, B Nan, C-N Wang, X Wang, L Junck, R D Chervin, F Consens, A Bhaumik. Neurology 2010
91
10




Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype.
J-P Taylor, E N Rowan, D Lett, J T O'Brien, I G McKeith, D J Burn. J Neurol Neurosurg Psychiatry 2008
48
10


Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity.
Lir-Wan Fan, Lu-Tai Tien, Baoying Zheng, Yi Pang, Rick C S Lin, Kimberly L Simpson, Tangeng Ma, Philip G Rhodes, Zhengwei Cai. Brain Behav Immun 2011
48
10



Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation.
Yeong-Renn Chen, Chwen-Lih Chen, Liwen Zhang, Kari B Green-Church, Jay L Zweier. J Biol Chem 2005
96
10

Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats.
Martin T Woodlee, Aloysha M Asseo-García, Xiurong Zhao, Shi-Jie Liu, Theresa A Jones, Timothy Schallert. Exp Neurol 2005
105
10

alpha-Phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats.
Lir-Wan Fan, Ruei-Feng Chen, Helen J Mitchell, Rick C S Lin, Kimberly L Simpson, Philip G Rhodes, Zhengwei Cai. J Neurosci Res 2008
30
10

A behavioural characterization of neonatal infection-facilitated memory impairment in adult rats.
Staci D Bilbo, Jerry W Rudy, Linda R Watkins, Steven F Maier. Behav Brain Res 2006
73
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.